Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008971
Filing Date
2022-05-10
Accepted
2022-05-10 16:10:07
Documents
64
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tptx-20220331.htm   iXBRL 10-Q 2335026
2 EX-10.2 tptx-ex10_2.htm EX-10.2 78715
3 EX-10.3 tptx-ex10_3.htm EX-10.3 38693
4 EX-10.4 tptx-ex10_4.htm EX-10.4 42192
5 EX-31.1 tptx-ex31_1.htm EX-31.1 23704
6 EX-31.2 tptx-ex31_2.htm EX-31.2 23275
7 EX-32.1 tptx-ex32_1.htm EX-32.1 12220
8 EX-32.2 tptx-ex32_2.htm EX-32.2 12240
  Complete submission text file 0000950170-22-008971.txt   8140310

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tptx-20220331.xsd EX-101.SCH 39193
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tptx-20220331_cal.xml EX-101.CAL 39178
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tptx-20220331_def.xml EX-101.DEF 163983
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tptx-20220331_pre.xml EX-101.PRE 291120
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tptx-20220331_lab.xml EX-101.LAB 372179
58 EXTRACTED XBRL INSTANCE DOCUMENT tptx-20220331_htm.xml XML 1543214
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

EIN.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38871 | Film No.: 22909675
SIC: 2834 Pharmaceutical Preparations